The role of the “gut microbiota-mitochondria” crosstalk in the pathogenesis of multiple sclerosis
Frontiers in Microbiology,
Год журнала:
2024,
Номер
15
Опубликована: Апрель 29, 2024
Multiple
Sclerosis
(MS)
is
a
neurologic
autoimmune
disease
whose
exact
pathophysiologic
mechanisms
remain
to
be
elucidated.
Recent
studies
have
shown
that
the
onset
and
progression
of
MS
are
associated
with
dysbiosis
gut
microbiota.
Similarly,
large
body
evidence
suggests
mitochondrial
dysfunction
may
also
significant
impact
on
development
MS.
Endosymbiotic
theory
has
found
human
mitochondria
microbial
in
origin
share
similar
biological
characteristics
Therefore,
microbiota
function
crosstalk
relevant
However,
relationship
between
not
fully
understood.
by
synthesizing
previous
literature,
this
paper
focuses
changes
metabolite
composition
possible
MS,
provide
new
therapeutic
approaches
for
prevention
or
reduction
based
crosstalk.
Язык: Английский
Regulation of Postoperative Cognitive Dysfunction by Glutathione Under Various Pathways: A Narrative Review
Journal of Biochemical and Molecular Toxicology,
Год журнала:
2025,
Номер
39(2)
Опубликована: Фев. 1, 2025
Postoperative
cognitive
dysfunction
(POCD)
is
a
common
neurological
complication
after
surgery
and
general
anesthesia,
the
incidence
increases
with
age.
Will
have
negative
impact
on
patients,
family
society.
At
present,
neuroinflammation
oxidative
stress
are
main
recognized
mechanisms.
Glutathione
(GSH)
powerful
reducing
agent
may
be
related
to
POCD.
Using
medical
search
engines
such
as
PubMed,
Web
of
Science,
we
analyzed
articles
topics
as:
POCD,
GSH,
microglia,
astrocyte,
oligodendrocyte,
ferroptosis,
BDNF,
Neuroinflammation,
stress.
The
above
searched
in
databases
using
Boolean
operations.
We
included
original
articles,
reviews
other
article
types
books.
According
reviewed
literature,
GSH
treatment
for
Specific
targeted
therapies
POCD
still
sparse,
therefore,
implementation
preventive
strategies
appears
remain
optimal
attitude.
Further
research
needed
better
understanding
Язык: Английский
Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Boost Functional Performance in an Animal Model of Multiple Sclerosis Through Recruiting Oligodendrocytes and Attenuating Gliosis
Stem Cell Reviews and Reports,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 7, 2025
Язык: Английский
Advances in the study of artemisinin and its derivatives for the treatment of rheumatic skeletal disorders, autoimmune inflammatory diseases, and autoimmune disorders: a comprehensive review
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Окт. 25, 2024
Artemisinin
and
its
derivatives
are
widely
recognized
as
first-line
treatments
for
malaria
worldwide.
Recent
studies
have
demonstrated
that
artemisinin-based
antimalarial
drugs,
such
artesunate,
dihydroartemisinin,
artemether,
not
only
possess
excellent
properties
but
also
exhibit
antitumor,
antifungal,
immunomodulatory
effects.
Researchers
globally
synthesized
artemisinin
like
SM735,
SM905,
SM934,
which
offer
advantages
low
toxicity,
high
bioavailability,
potential
immunosuppressive
properties.
These
compounds
induce
immunosuppression
by
inhibiting
the
activation
of
pathogenic
T
cells,
suppressing
B
cell
antibody
production,
enhancing
differentiation
regulatory
cells.
This
review
summarized
mechanisms
analogs
modulate
excessive
inflammation
immune
responses
in
rheumatic
skeletal
diseases,
autoimmune
inflammatory
disorders,
through
pathways
including
TNF,
Toll-like
receptors,
IL-6,
RANKL,
MAPK,
PI3K/AKT/mTOR,
JAK/STAT,
NRF2/GPX4.
Notably,
context
NF-κB
pathway,
inhibits
expression
disrupting
upstream
cascades
and/or
directly
binding
to
downregulates
multiple
downstream
genes
controlled
NF-κB,
chemokines
their
receptors.
targets
regulate
various
functions,
apoptosis,
proliferation,
signal
transduction,
antioxidant
responses,
ultimately
intervening
systemic
diseases
organs
kidneys,
nervous
system,
skin,
liver,
biliary
system
modulating
dysregulation
responses.
Ongoing
multicenter
randomized
clinical
trials
investigating
effects
these
on
rheumatic,
inflammatory,
with
aim
translating
promising
preclinical
data
into
applications.
Язык: Английский
Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management
Seth Woodfin,
S. S. HALL,
Alexis Ramerth
и другие.
Nutrients,
Год журнала:
2024,
Номер
16(17), С. 2996 - 2996
Опубликована: Сен. 5, 2024
Multiple
sclerosis
(MS)
is
a
chronic
autoimmune
disorder
characterized
by
inflammation,
demyelination,
and
neurodegeneration,
resulting
in
significant
disability
reduced
quality
of
life.
Current
therapeutic
strategies
primarily
target
immune
dysregulation,
but
limitations
efficacy
tolerability
highlight
the
need
for
alternative
treatments.
Plant-derived
compounds,
including
alkaloids,
phenylpropanoids,
terpenoids,
have
demonstrated
anti-inflammatory
effects
both
preclinical
clinical
studies.
By
modulating
responses
promoting
neuroregeneration,
these
compounds
offer
potential
as
novel
adjunctive
therapies
MS.
This
review
provides
insights
into
molecular
cellular
basis
MS
pathogenesis,
emphasizing
role
inflammation
disease
progression.
It
critically
evaluates
emerging
evidence
supporting
use
plant-derived
to
attenuate
symptomology.
In
addition,
we
provide
comprehensive
source
information
detailing
known
mechanisms
action
assessing
context
with
focus
on
their
neuroprotective
properties.
Язык: Английский
Immunoglobulin G and Complement as Major Players in the Neurodegeneration of Multiple Sclerosis
Biomolecules,
Год журнала:
2024,
Номер
14(10), С. 1210 - 1210
Опубликована: Сен. 26, 2024
Multiple
Sclerosis
(MS)
is
an
inflammatory,
demyelinating,
and
neurodegenerative
disease
of
the
central
nervous
system
(CNS)
termed
as
one
most
common
causes
neurological
disability
in
young
adults.
Axonal
loss
neuronal
cell
damage
are
primary
progression
disability.
Yet,
little
known
about
mechanism
neurodegeneration
disease,
a
limitation
that
impairs
development
more
effective
treatments
for
progressive
MS.
MS
characterized
by
presence
oligoclonal
bands
raised
levels
immunoglobulins
CNS.
The
role
complement
demyelinating
process
has
been
detected
both
experimental
animal
models
within
CNS
affected
patients.
Furthermore,
IgG
antibodies
activation
can
be
plaques
cortical
gray
matter
lesions.
We
propose
here
play
active
hypothesize
increased
form
aggregates
bind
C1q
with
high
affinity,
activating
classical
pathway.
This
results
damage,
which
leads
to
demyelination
Язык: Английский
Causal relationship between thyroid function and multiple sclerosis: A bidirectional Mendelian randomization study
Medicine,
Год журнала:
2024,
Номер
103(37), С. e39709 - e39709
Опубликована: Сен. 13, 2024
An
association
between
thyroid
function
and
multiple
sclerosis
(MS)
has
been
reported
in
several
observational
studies,
but
the
causal
relationship
them
is
still
unclear.
Thus,
this
study
used
a
bidirectional
Mendelian
randomization
(MR)
to
investigate
associations
MS.
Bidirectional
MR
was
explore
(thyroid-stimulating
hormone
[TSH],
free
thyroxine
[FT4],
hyperthyroidism,
hypothyroidism)
Genome-wide
(GWAS)
data
of
MS
were
obtained
from
ThyroidOmics
Consortium
FinnGen
Consortium,
respectively.
Inverse-variance
weighted
method
(IVW)
primary
analysis
assess
causality
with
Weighted
median,
MR-Egger
regression,
mode,
simple
mode
as
auxiliary
methods.
Sensitivity
analyses
performed
using
heterogeneity
tests,
horizontal
pleiotropy
tests
leave-one-out
method.
There
positive
TSH
(IVW:
OR
=
1.202,
95%
CI:
1.040–1.389,
P
.013),
no
strong
evidence
found
for
an
effect
FT4
1.286,
0.990–1.671,
.059),
hypothyroidism
1.247,
0.961–1.617,
.096),
hyperthyroidism
0.966,
0.907–1.030,
.291)
on
risk
In
reverse
results,
there
β
−0.009,
.184),
−0.011,
.286),
0.992,
0.944–1.042,
.745),
1.026,
0.943–1.117,
.549).
Cochran’s
Q
test,
intercept
MR-PRESSO
global
Leave-one-out
did
not
observe
heterogeneity.
conclusion,
supported
Язык: Английский